Compare PKOH & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PKOH | VALN |
|---|---|---|
| Founded | 1907 | 2012 |
| Country | United States | France |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 686.7M | 653.3M |
| IPO Year | 1994 | 2021 |
| Metric | PKOH | VALN |
|---|---|---|
| Price | $46.45 | $6.66 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $37.00 | $15.50 |
| AVG Volume (30 Days) | 81.2K | ★ 81.9K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | ★ 1.69% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.43 | N/A |
| Revenue | ★ $1,599,100,000.00 | N/A |
| Revenue This Year | $7.87 | N/A |
| Revenue Next Year | $3.42 | $93.87 |
| P/E Ratio | $32.73 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $18.43 | $4.75 |
| 52 Week High | $53.30 | $12.23 |
| Indicator | PKOH | VALN |
|---|---|---|
| Relative Strength Index (RSI) | 51.52 | 57.83 |
| Support Level | $44.42 | $5.10 |
| Resistance Level | $47.69 | $7.31 |
| Average True Range (ATR) | 1.68 | 0.23 |
| MACD | -0.30 | -0.05 |
| Stochastic Oscillator | 42.47 | 47.78 |
Park-Ohio Holdings Corp is a diversified international company offering its clients supply chain management outsourcing services, capital equipment used on their production lines, and manufactured components used to assemble their products. The company operates through three reportable segments: Supply Technologies, Assembly Components, and Engineered Products. Maximum revenue is generated from the Supply Technologies segment, which is mainly engaged in sourcing, planning, and procurement of several production components, including fasteners, pins, nuts, bolts, valves, hoses, wire harnesses, clamps and fittings, etc. Geographically, the company generates maximum revenue from its business in the United States, followed by Europe, Asia, Mexico, Canada, and other regions.
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.